RSLS (ReShape Lifesciences Inc) Prakiraan pendapatan perusahaan
ReShape Lifesciences (RSLS) efficiency relies on the popularity of Lap-Band systems and FDA approval. The company's projected sales metric in daily price action on the GURU.Markets chart is 0.01. Cost optimization is achieved through contract electronics assembly, while growth is driven by recruiting leading innovative engineers in the field of obesity treatment.
Rincian analitis lan laporan data perusahaan ReShape Lifesciences Inc (RSLS)
- rega saiki lan proyeksi nilai saham:
- indikator valuasi pasar bisnis:
- data ekuitas miturut neraca:
- indikator beban kredit lan likuiditas emiten:
Total Utang marang Modal ReShape Lifesciences|RSLS - Rasio tanggungan utang jangka dawa marang modal|Utang jangka cendhak marang modal ReShape Lifesciences|RSLS - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku ReShape Lifesciences, Inc.|RSLS - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan ReShape Lifesciences|Indikator likuiditas cepet reshapelifesciences.com
- statistik bathi lan rasio pasar:
RSLS - Bathi pungkasan|Proyeksi bathi mangsa ngarep ReShape Lifesciences|RSLS - Kapitalisasi marang bathi|Rega marang bathi mangsa ngarep ReShape Lifesciences|RSLS - Rasio rega marang wutah bathi resik|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan ReShape Lifesciences, Inc.|RSLS - Bathi operasional EBITDA|Bathi resik saben saham (EPS TTM) ReShape Lifesciences|RSLS - Bathi resik saben saham sajrone patang kuartal pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan reshapelifesciences.com|RSLS - Dinamika bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep ReShape Lifesciences
- data dodolan lan asil:
Analisis fundamental perusahaan:ReShape Lifesciences Inc.
ReShape Lifesciences (RSLS) business is heavily dependent on the bariatric surgery segment, which creates risks due to the expansion of new weight-loss drugs. The f_sales_co calculation model estimates future cash flows based on market share expansion rates. The organization's current projected sales volume is fixed at 0.01. The dynamics of this indicator demonstrate the actual scale of product commercialization. A sharp increase in the curve may signal a revaluation of the cost of capital.
Analisis perusahaan pesaing
Volume dodolan mangsa ngarep perusahaan DXCM (DexCom, Inc.)|PEN (penumbrainc.com) - Pendapatan mangsa ngarep perusahaan|Prakiraan pendapatan perusahaan Novanta NOVT|HAE - Volume dodolan mangsa ngarep perusahaan|Inspire Sleep - Prakiraan volume dodolan|Volume dodolan sing dikarepake perusahaan Procept|CNMD: Prakiraan volume dodolan|Prakiraan pendapatan perusahaan PLSE|INMD (InMode) - Prakiraan volume dodolan|Picard Medical Corp (PMI) - Dodolan mangsa ngarep perusahaan|Prakiraan volume dodolan SRDX|Volume dodolan mangsa ngarep perusahaan Eversense SENS|Prakiraan volume dodolan NPCE (NeuroPace, Inc.)|Prakiraan volume dodolan Tactile Systems Technology, Inc. TCMD|SNWV - Prakiraan pendapatan perusahaan|OM: Prakiraan pendapatan perusahaan|ELMD (smartvest.com) - Volume dodolan mangsa ngarep perusahaan|LENSAR Inc - Pendapatan mangsa ngarep perusahaan|RCEL (AVITA Medical, Inc.) - Prakiraan volume dodolan|Volume dodolan sing dikarepake perusahaan Profound Medical Corporation PROF|Prakiraan pendapatan perusahaan Baird Medical Investment (BDMD)|edap-tms.com (EDAP) - Prakiraan dodolan perusahaan|Apyx Medical Corporation - Volume dodolan mangsa ngarep perusahaan|Prakiraan volume dodolan IceCure Medical Ltd. ICCM|Pulmonx Corp. - Prakiraan volume dodolan|Dodolan mangsa ngarep perusahaan TELA Bio, Inc. TELA|cytosorbents.com (CTSO) - Prakiraan pendapatan perusahaan|Pendapatan sing dikarepake perusahaan SRTS (Sensus Healthcare Inc)|Prakiraan pendapatan perusahaan Zynex Inc|Volume dodolan mangsa ngarep perusahaan electroCore Medical (ECOR)|Prakiraan volume dodolan RBOT|IINN - Volume dodolan sing dikarepake perusahaan|Prakiraan pendapatan perusahaan SeaStar Medical ICU|IRIX: Prakiraan pendapatan perusahaan|INBS: Volume dodolan mangsa ngarep perusahaan|Beyond Air, Inc. - Prakiraan volume pendapatan perusahaan|Profusa Inc (PFSA) - Prakiraan pendapatan perusahaan|STRATA Skin Sciences, Inc. - Pendapatan mangsa ngarep perusahaan|GCTK (GlucoTrack, Inc.) - Prakiraan volume dodolan|Volume dodolan sing dikarepake perusahaan nanovibronix.com NAOV|Prakiraan pendapatan perusahaan Venus Concept Corp (VERO)|Dodolan mangsa ngarep perusahaan Nuwellis Corp|Prakiraan volume dodolan AEMD (Aethlon Medical)|Pendapatan mangsa ngarep perusahaan ASXC|Avinger - Prakiraan volume dodolan|BSGM - Prakiraan volume dodolan|Cutera, Inc (CUTR) - Prakiraan pendapatan perusahaan|Pendapatan sing dikarepake perusahaan KNW (Know Labs Corporation)|NARI (Inari Medical, Inc.) - Prakiraan volume dodolan|Volume dodolan sing dikarepake perusahaan nevro.com NVRO|Volume dodolan mangsa ngarep perusahaan SILK (Silk Road Medical)
